SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (17094)3/10/1998 3:38:00 PM
From: Abuckatatime  Read Replies (4) | Respond to of 32384
 
"fat STATS" and other goodies. Leptin review article in Lancet. Get it while you can as The Lancet is revamping the site and access to full-text articles will be available only to subscribers in a couple of weeks.
thelancet.com



To: Henry Niman who wrote (17094)3/10/1998 9:20:00 PM
From: Flagrante Delictu  Read Replies (4) | Respond to of 32384
 
Henry, Re: Evista in Canada? The problem I see with Evista in Canada is that the current sales force targets cancer specialists. They would have to learn about women's health issues & get to know a whole new kind of specialists in women's health. Bernie


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News